Venture Life Group plc (VLG.L)

39,00 0,00 (0,00%) In data: 11:26AM BST. Mercato aperto.

Venture Life Group plc

12 The Courtyard
Eastern Road
Bracknell RG12 2XB
United Kingdom
44 13 4457 8004
https://www.venture-life.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 165

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Jeremy Anthony Philip Randall ACA	Co-Founder, CEO & Executive Director	495,99k	N/D	1964
Mr. Daniel James Wells	CFO & Director	344,02k	N/D	1987
Mr. Lodovico Gianluca Braguti	Chief Manufacturing Officer & Executive Director	424,66k	N/D	1960
Ben Colman	Director of Corporate Development	N/D	N/D	N/D
Mr. Domenico Barbaro	Head of Procurement	N/D	N/D	N/D
Mr. Ennio Schiro	Head of ESG Strategy	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in GBp.

Descrizione

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Governance aziendale

L'ISS Governance QualityScore di Venture Life Group plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.